Literature DB >> 6074002

Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A.

Y Takeda, A Y Chen.   

Abstract

Using autologous (131)I-fibrinogen, we made studies of the metabolism and distribution of fibrinogen in 10 patients with hemophilia A. In two patients simultaneous studies of autologous (131)I-fibrinogen and homologous (125)I-fibrinogen prepared from healthy donors' plasma were carried out. The average value for the plasma volume was 42.1 +/- 8.8 ml/kg; for the plasma fibrinogen concentration, 349 +/- 90 mg/100 ml; for the intravascular fibrinogen, 144 +/- 32 mg/kg; for the interstitial fibrinogen, 30 +/- 11 mg/kg; for the slower half-life of (131)I-fibrinogen, 2.34 +/- 0.17 days; for the transcapillary transfer rate of fibrinogen, 109 +/- 37 mg/kg per day; and for the catabolic and synthetic rates of fibrinogen, 51.7 +/- 13.1 mg/kg per day. Comparison of these results with those of the previous study in healthy male subjects showed that in patients with hemophilia A the catabolic and synthetic rates of fibrinogen are markedly increased, whereas the plasma fibrinogen concentration, intravascular and interstitial fibrinogen, and the transcapillary transfer rate of fibrinogen are not significantly different. The simultaneous studies of autologous (131)I-fibrinogen and normal homologous (125)I-fibrinogen in two subjects revealed that the two preparations behaved very similarly. Based on these findings, we concluded that our present findings are not due to the qualitative difference between the hemophilia A and normal fibrinogens, but that they are due to the difference in the host condition with respect to the fibrinogen metabolism, which is either an increased rate of direct breakdown of fibrinogen or an increased rate of fibrinogen breakdown after fibrin formation, or both.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6074002      PMCID: PMC292950          DOI: 10.1172/JCI105687

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Platelet and fibrinogen survival in normal and abnormal states of coagulation.

Authors:  E ADELSON; J J RHEINGOLD; O PARKER; A BUENAVENTURA; W H CROSBY
Journal:  Blood       Date:  1961-03       Impact factor: 22.113

2.  Mathematical models describing the distribution of I-131-albumin in man.

Authors:  E B REEVE; H R BAILEY
Journal:  J Lab Clin Med       Date:  1962-12

3.  The turnover of plasma fibrinogen.

Authors:  L K CHRISTENSEN
Journal:  Acta Med Scand       Date:  1958-11-27

4.  Clotting deviations in man associated with open-heart surgery during hypothermia.

Authors:  K N VON KAULLA; H SWAN
Journal:  J Thorac Surg       Date:  1958-12

5.  Methods for the evaluation of human fibrinolysis; studies with two combined technics.

Authors:  K N VON KAULLA; R L SCHULTZ
Journal:  Am J Clin Pathol       Date:  1958-02       Impact factor: 2.493

6.  A study of fibrinogen turnover in classical hemophilia and congenital afibrinogenemia.

Authors:  A R RAUSEN; A CRUCHAUD; C W McMILLAN; D GITLIN
Journal:  Blood       Date:  1961-12       Impact factor: 22.113

7.  Epsilon-aminocaproic acid therapy for dental extractions in haemophiliacs.

Authors:  M W Cooksey; C B Perry; A B Raper
Journal:  Br Med J       Date:  1966-12-31

8.  The biological half-life of I-131 fibrinogen.

Authors:  H C Hart
Journal:  Thromb Diath Haemorrh Suppl       Date:  1965

9.  Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa.

Authors:  B Blombäck; L A Carlson; S Franzén; E Zetterqvist
Journal:  Acta Med Scand       Date:  1966-05

10.  Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen.

Authors:  Y Takeda
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

View more
  4 in total

1.  Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury.

Authors:  Y Takeda
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

Review 2.  The hemostasis system in murine atherosclerosis.

Authors:  Takayuki Iwaki; Victoria A Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

3.  Human prothrombin metabolism in normal man and in hypocoagulable subjects.

Authors:  S S Shapiro; J Martinez
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

4.  CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.

Authors:  Sadna Budhu; John D Loike; Ashley Pandolfi; Soo Han; Geoffrey Catalano; Andrei Constantinescu; Raphael Clynes; Samuel C Silverstein
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.